Trial Profile
PD 0200390 Dose-Ranging Trial: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Outpatient Trial of PD 0200390 in Adults With Nonrestorative Sleep.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jul 2012
Price :
$35
*
At a glance
- Drugs Atagabalin (Primary)
- Indications Sleep disorders
- Focus Therapeutic Use
- 24 Jul 2012 Additional location (Canada) added as reported by ClinicalTrials.gov.
- 20 Jan 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 20 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.